No hospital or health facility may interfere with the physician-patient relationship by restricting or forbidding the use of amygdalin when prescribed or administered by a licensed physician and requested by a patient unless the substance as prescribed or administered by the physician is found to be harmful by the North Dakota board of medicine in a hearing conducted pursuant to chapter 28-32.
N.D. Cent. Code § 23-23.1-01
Use of laetrile authorized
Official source: North Dakota Legislative Branch. Reproduced from public-domain North Dakota statutes; confirm against the official source for the current text. Not legal advice.